CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection.
Raphael I, Mujeeb AA, Ampudia-Mesias E, Sever RE, McClellan B, Frederico SC, Sneiderman CT, Mirji A, Daba A, Puerta-Martinez F, Nisnboym M, Edwards WB, Graner M, Moertel CL, Castro MG, Kohanbash G, Olin MR.
Raphael I, et al. Among authors: olin mr.
bioRxiv [Preprint]. 2024 Sep 10:2024.09.08.611922. doi: 10.1101/2024.09.08.611922.
bioRxiv. 2024.
PMID: 39314283
Free PMC article.
Preprint.